A Long-Term Extension Study of IMVT-1402 in Adult Participants With Graves' Disease (GD)
NCT07286006
·
clinicaltrials.gov ↗
PHASE2
Phase
ENROLLING_BY_INVITATION
Status
372
Enrollment
INDUSTRY
Sponsor class
Conditions
Graves' Disease
Interventions
DRUG:
IMVT-1402
Sponsor
Immunovant Sciences GmbH